Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes | Zendy

Ahmed S. T. | Zendy; Akirav E. | Zendy; Bradshaw E. | Zendy; Buckner J. | Zendy; McKinney E. | Zendy; Quintana F. J. | Zendy; WaldronLynch F. | Zendy; Nepom J. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes

Author(s) -

Ahmed S. T.,

Akirav E.,

Bradshaw E.,

Buckner J.,

McKinney E.,

Quintana F. J.,

WaldronLynch F.,

Nepom J.

Publication year - 2013

Publication title -

clinical & experimental immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.329

H-Index - 135

eISSN - 1365-2249

pISSN - 0009-9104

DOI - 10.1111/cei.12063

Subject(s) - immunology , autoimmunity , diabetes mellitus , medicine , autoimmune diabetes , autoimmune disease , immune system , antibody , endocrinology

Summary In a recent workshop organized by the JDRF focused on the ‘Identification and Utilization of Robust Biomarkers in Type1 Diabetes’, leaders in the field of type 1 diabetes ( T1D )/autoimmunity and assay technology came together from academia, government and industry to assess the current state of the field, evaluate available resources/technologies and identify gaps that need to be filled for moving the field of T1D research forward. The highlights of this workshop are discussed in this paper, as well as the proposal for a larger, planned consortium effort, incorporating a JDRF Biomarker Core, to foster collaboration and accelerate progress in this critically needed area of T1D research.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research